Stock Fundamentals

Company Information

Company Name
Nevro Corp
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
ISIN: US64157F1030
CIK: 0001444380
CUSIP: 64157F103
Currency: USD
Full Time Employees: 1,099
Phone: 650 251 0005
Fiscal Year End: December
IPO Date: Nov 06, 2014
Description:

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS systems. It also offers Senza HFX iQ platform that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, the company provides HFX AdaptivAI, a pain management platform that powers the HFX iQ SCS system, as well as surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is based in Redwood City, California.

Address:

1800 Bridge Parkway, Redwood City, CA, United States, 94065

Directors & Officers

Name Title Year Born
Mr. Kevin R. Thornal President, CEO & Director 1974
Mr. Roderick H. MacLeod Senior VP & CFO 1967
Mr. Kashif Rashid J.D. Senior VP of Corporate Development & Chief Legal Officer 1975
Mr. Greg Siller Senior VP & Chief Commercial Officer 1981
Mr. Christofer Christoforou Senior VP & COO 1970
Ms. Angeline C. McCabe Vice President of Investor Relations & Corporate Communications NA
Ms. Shana D. Ross M.B.A. Senior VP & Chief Human Resources Officer 1973
Dr. David Caraway M.D., Ph.D. Senior VP & Chief Medical Officer 1957
Mr. Peter A. Socarras VP, General Counsel & Corporate Secretary 1981

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jun 07, 2023 Shawn Mccormick N/A Purchase 7.50K $22.88 $171.60K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Engineers Gate Manager LP 113.19K Mar 31, 2025 0.30% $0.01 -3.25%

Shares Statistics

Shares Outstanding: 38.37M
Shares Float: 34.23M
% Insiders: 283.70%
% Institutions: 11,059.00%
Short % Float: 5.13%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 GAMCO Intl SICAV Merger Arbtrg I (USD) 377.77K 0.98% ▲ 0.00% Feb 28, 2025
2 Fidelity Small Cap Index 366.51K 0.96% ▼ 0.58% Mar 31, 2025
3 Fidelity Extended Market Index 209.38K 0.55% ▲ 3.52% Mar 31, 2025
4 Nissay Glbl Digital Hlthcare Eq MF 184.40K 0.48% ▲ 29.49% Nov 18, 2024
5 AltShares Merger Arbitrage ETF 114.72K 0.30% ▲ 0.00% Feb 28, 2025
6 NT R2000 Index Fund - NL 89.23K 0.23% ▲ 2.73% Mar 31, 2025
7 1290 VT GAMCO Mergers & Acquisitions IB 88.50K 0.23% ▲ 36.15% Mar 31, 2025
8 Vanguard Growth & Income Inv 81.50K 0.21% ▼ 52.81% Mar 31, 2025
9 Extended Equity Market Fund K 79.08K 0.21% ▲ 0.31% Mar 31, 2025
10 Fidelity Total Market Index 72.00K 0.19% ▲ 8.30% Mar 31, 2025

Valuation Metrics

Enterprise Value: $182.72M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $224.09M
EBITDA: $-83.80M
PEG Ratio: $-3.13
Book Value: $6.11
Earnings/Share: $-3.06
Profit Margin: -27.77%
Operating Margin: -21.79%
ROA (TTM): -9.95%
ROE (TTM): -43.29%
Revenue (TTM): $408.52M
Revenue/Share (TTM): $11.02
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -9.10%

Stock Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 4.62x 0.98x 0.58x -4.69x -1.79x
2023-12-31 6.37x 0.74x 0.54x -12.39x -2.77x
2022-12-31 7.11x 0.59x 0.46x -15.37x 9.14x
2021-12-31 6.46x 0.51x 0.47x -4.60x -1.52x
2020-12-31 3.15x 0.81x 0.51x -2.88x -5.75x
2019-12-31 5.98x 0.76x 0.54x -8.83x -1.85x
2018-12-31 7.11x 0.62x 0.47x -4.01x -4.03x
2017-12-31 7.61x 1.16x 0.45x -2.99x -10.71x
2016-12-31 9.96x 1.11x 0.42x -3.61x -12.53x
2015-12-31 7.77x 0.17x 0.19x -22.83x -0.64x
2014-12-31 18.63x 0.23x 0.15x -1,769.13x -1.38x
2013-12-31 9.46x 0.00x 0.11x N/A 0.00x
2012-12-31 9.30x 0.00x 0.11x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NVRO.US!